PATENT CLAIM ANALYSIS

Application Number: 16092574
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "490000"]

Abstract:
The invention relates to a granule formulation that enables cariprazine hydrochloride to be stably stored. The solution provides a granule formulation containing cariprazine hydrochloride, wherein said granule formulation contains lactose as a primary diluent.

Claim (Index 4):
A granule formulation for oral administration according to any one of  claims 1  to  3 , wherein said granule formulation contains one or more types of fluidizer at a percentage content of 0 to 5 wt %, selected from light anhydrous silicic acid, hydrous silicon dioxide, stearic acid, calcium stearate, magnesium stearate, sodium stearyl fumarate, sugar fatty acid ester, titanium oxide, talc, dibasic calcium phosphate or its hydrate, corn starch, magnesium aluminometasilicate and sodium lauryl sulfate.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 97.0
- Lexical Diversity: 1.42308
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12504149', '13653576', '15108940', '12376060', '15515555']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6759225076483827
- 35 USC 102 Novelty (BERT): 0.4878748171359015
- Combined Prediction Score: 0.6571177385971346
- Mean Citation Score: 151.99829
- Max Citation Score: 161.73233000000005
- Similarity Product: 113.1241724496335

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test